Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.

Inga transaktioner
Se i superdiagram

LCTX fundamenta

Lineage Cell Therapeutics, Inc. earnings per share and revenue

LCTX earnings per share for the last quarter are -0.04 USD whereas the estimation was -0.04 USD which accounts for -4.35% surprise. Företagets omsättning för samma period uppgår till 1.44 M USD trots den uppskattade siffran 1.36 M USD. Estimated earnings per share for the next quarter are -0.04 USD, and revenue is expected to reach 786.00 k USD. Also watch annual changes over time to get a bigger picture of LCTX earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning